# Tristan Mirault

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/tristan-mirault/

## Facts

| Field | Value |
| --- | --- |
| Citations | 12,583 |
| Field | Peripheral Artery Disease Management |
| h-index | 41 |
| i10-index | 113 |
| Last Known Institution | Inserm |
| OpenAlex ID | https://openalex.org/A5001852101 |
| ORCID iD | 0000-0001-8690-1093 |
| Works | 300 |

## Researcher papers

- [Autoantibodies against type I IFNs in patients with life-threatening COVID-19](https://scholariq.org/papers/autoantibodies-against-type-i-ifns-in-patients-with-life-threatening-covid-19/)
- [Inborn errors of type I IFN immunity in patients with life-threatening COVID-19](https://scholariq.org/papers/inborn-errors-of-type-i-ifn-immunity-in-patients-with-life-threatening-covid-19/)
- [2024 ESC Guidelines for the management of peripheral arterial and aortic diseases](https://scholariq.org/papers/2024-esc-guidelines-for-the-management-of-peripheral-arterial-and-aortic/)
- [Retrospective Analysis of Surgery Versus Endovascular Intervention in Takayasu Arteritis](https://scholariq.org/papers/retrospective-analysis-of-surgery-versus-endovascular-intervention-in-takayasu/)
- [The Changing Landscape for Stroke Prevention in AF](https://scholariq.org/papers/the-changing-landscape-for-stroke-prevention-in-af/)
- [Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients](https://scholariq.org/papers/angiopoietin-2-as-a-marker-of-endothelial-activation-is-a-good-predictor-factor/)
- [Long-Term Outcomes and Prognostic Factors of Complications in Takayasu Arteritis](https://scholariq.org/papers/long-term-outcomes-and-prognostic-factors-of-complications-in-takayasu-arteritis/)
- [The type of variants at the COL3A1 gene associates with the phenotype and severity of vascular Ehlers–Danlos syndrome](https://scholariq.org/papers/the-type-of-variants-at-the-col3a1-gene-associates-with-the-phenotype-and/)
- [Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinib](https://scholariq.org/papers/peripheral-artery-occlusive-disease-in-chronic-phase-chronic-myeloid-leukemia/)
- [The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies](https://scholariq.org/papers/the-risk-of-covid-19-death-is-much-greater-and-age-dependent-with-type-i-ifn/)
- [Prior participation as a standardized patient improves OSCE scores of third-year medical students: A pilot comparative study at Université Paris Cité Medical School](https://scholariq.org/papers/prior-participation-as-a-standardized-patient-improves-osce-scores-of-third-year/)

## Researcher topics

- [Peripheral Artery Disease Management](https://scholariq.org/topics/peripheral-artery-disease-management/)
- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Cerebrovascular and Carotid Artery Diseases](https://scholariq.org/topics/cerebrovascular-and-carotid-artery-diseases/)

## Researcher university

- [Inserm](https://scholariq.org/institutions/inserm/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.